SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-019528
Filing Date
2022-04-13
Accepted
2022-04-13 09:28:20
Documents
15
Period of Report
2022-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT FILING ea158351-8k_citius.htm   iXBRL 8-K 29106
2 PRESS RELEASE DATED APRIL 13, 2022. ea158351ex99-1_citius.htm EX-99.1 14649
3 GRAPHIC image_001.jpg GRAPHIC 4477
  Complete submission text file 0001213900-22-019528.txt   274392

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ctxr-20220412.xsd EX-101.SCH 3681
5 XBRL DEFINITION FILE ctxr-20220412_def.xml EX-101.DEF 26572
6 XBRL LABEL FILE ctxr-20220412_lab.xml EX-101.LAB 36574
7 XBRL PRESENTATION FILE ctxr-20220412_pre.xml EX-101.PRE 25196
9 EXTRACTED XBRL INSTANCE DOCUMENT ea158351-8k_citius_htm.xml XML 5345
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 22823848
SIC: 2834 Pharmaceutical Preparations